Current Report Filing (8-k)
July 16 2020 - 6:00AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported): July
14, 2020
LIFELOC TECHNOLOGIES, INC.
(Exact name of registrant as specified in
its charter)
Colorado
|
|
000-54319
|
|
84-1053680
|
(State or other jurisdiction of incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer Identification Number)
|
12441 West 49th Ave., Unit 4
|
|
|
Wheat Ridge, CO
|
|
80033
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
(303) 431-9500
(Registrant’s telephone number, including
area code)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[_]
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
[_]
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
[_]
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
[_]
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
[_]
If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. [_]
Securities registered pursuant to Section
12(b) of the Act:
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock
|
LCTC
|
N/A
|
Item 8.01 Other Events.
On July 14, 2020,
Lifeloc Technologies, Inc. (the “Company”) issued a press release announcing the results of a study aimed at determining
risk of subject to subject virus transmission through select Company products. A copy of the press release is furnished herewith
as Exhibit 99.1.
The information in
this Form 8-K, including the exhibit attached hereto, is being “furnished” and shall not be deemed “filed”
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of
that section, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933, as amended,
unless expressly set forth by specific reference in such filing that such information is incorporated by reference therein.
Item 9.01 Financial
Statements and Exhibits.
(d) Exhibits.
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: July 15, 2020
|
LIFELOC TECHNOLOGIES, INC.
|
|
|
|
|
By:
|
/s/ Vern D. Kornelsen
|
|
|
Chief Financial Officer and Secretary
|
Lifeloc Technologies (PK) (USOTC:LCTC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Lifeloc Technologies (PK) (USOTC:LCTC)
Historical Stock Chart
From Apr 2023 to Apr 2024